• LAST PRICE
    6.1000
  • TODAY'S CHANGE (%)
    Trending Down-0.2200 (-3.4810%)
  • Bid / Lots
    5.9900/ 10
  • Ask / Lots
    6.3200/ 2
  • Open / Previous Close
    6.1700 / 6.3200
  • Day Range
    Low 5.9600
    High 6.3200
  • 52 Week Range
    Low 3.5100
    High 9.9600
  • Volume
    49,589
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 6.32
TimeVolumeXBIT
09:32 ET12916.17
09:36 ET1006.13
09:41 ET1006.19
09:54 ET3166.2
09:56 ET1006.18
11:15 ET1006.16
11:20 ET17756.055
11:24 ET10456.0642
11:58 ET1005.98
12:00 ET1006.07
12:18 ET1005.98
12:20 ET1006.02
12:21 ET1006.04
12:23 ET1006.015
12:27 ET2006
12:32 ET8526
12:36 ET1406.015
12:39 ET1006
12:52 ET3006
12:54 ET1006.015
12:57 ET1006.03
01:12 ET1006
01:14 ET1006.03
01:19 ET57015.995
01:21 ET6406.035
01:26 ET9006.07
01:39 ET3506.3181
01:44 ET1006.32
02:09 ET13516.13
02:11 ET11006.08
02:15 ET3006.0301
02:18 ET5056.07
02:29 ET2256.08
02:38 ET2006.08
02:42 ET2516.045
02:54 ET4006.06
02:58 ET1006.1
03:09 ET2006.16
03:25 ET5206.1444
03:32 ET4986.1
03:34 ET12076.06
03:38 ET8686.065
03:39 ET1646.05
03:41 ET2006.04
03:43 ET10006.085
03:45 ET1006.1
03:50 ET2006.09
03:52 ET2006.11
03:56 ET12086.14
03:57 ET17366.1
03:59 ET4006.1
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXBIT
XBiotech Inc
185.8M
-6.0x
---
United StatesTRVI
Trevi Therapeutics Inc
186.7M
-7.8x
---
United StatesIVVD
Invivyd Inc
188.5M
-0.8x
---
United StatesGLSI
Greenwich Lifesciences Inc
190.1M
-20.5x
---
United StatesOTLK
Outlook Therapeutics Inc
179.5M
-0.7x
---
United StatesELEV
Elevation Oncology Inc
176.5M
-3.1x
---
As of 2024-06-15

Company Information

XBiotech Inc. is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating a variety of diseases, such as inflammatory conditions like rheumatology, infectious disease, cardiovascular disease and cancer. The Company's True Human monoclonal antibodies are derived from human donors that mount a natural human immune response. The Company is focused on therapies that block a potent substance, known as interleukin-1 alpha (IL-1a), that mediates a number of pathophysiological processes including tissue breakdown (i.e. synovium, cartilage, bone), paraneoplastic angiogenesis and tumor stroma remodeling, formation of blood clots, malaise, muscle wasting and general inflammation. It has various candidate products including Natrunix. It has a clinical-stage therapeutic for methicillin resistant Staphylococcus aureus (MRSA), and several pre-clinical-stage therapeutics, including an oral delivery antibody therapeutic for colon infection by C. difficile.

Contact Information

Headquarters
5217 WINNEBAGO LANEAUSTIN, TX, United States 78744
Phone
512-386-2900
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer, Founder
John Simard
Director of Finance
Angela Hu
Chief Scientific Officer
Sushma Shivaswamy
Lead Independent Director
Jan-Paul Waldin
Independent Director
Peter Libby

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$185.8M
Revenue (TTM)
$0.00
Shares Outstanding
30.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.42
EPS
$-1.01
Book Value
$7.19
P/E Ratio
-6.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.